These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9880547)

  • 41. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA
    Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
    Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
    J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Degradation of an ubiquitin-conjugated protein is associated with myoblast differentiation in primary cell culture.
    Gardrat F; Montel V; Raymond J; Azanza JL
    Biochem Mol Biol Int; 1999 Mar; 47(3):387-96. PubMed ID: 10204075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60).
    Kraft AS; Baker VV; May WS
    Oncogene; 1987 May; 1(2):111-8. PubMed ID: 3325877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
    Joseph TW; Zaika A; Moll UM
    FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stabilization of p53 by adenovirus E1A occurs through its amino-terminal region by modification of the ubiquitin-proteasome pathway.
    Nakajima T; Morita K; Tsunoda H; Imajoh-Ohmi S; Tanaka H; Yasuda H; Oda K
    J Biol Chem; 1998 Aug; 273(32):20036-45. PubMed ID: 9685342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389.
    Huang C; Ma WY; Maxiner A; Sun Y; Dong Z
    J Biol Chem; 1999 Apr; 274(18):12229-35. PubMed ID: 10212189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective activation by bryostatin-1 demonstrates unique roles for PKC epsilon in neurite extension and tau phosphorylation.
    Ekinci FJ; Shea TB
    Int J Dev Neurosci; 1997 Nov; 15(7):867-74. PubMed ID: 9568534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ubiquitin, E6-AP, and their role in p53 inactivation.
    Scheffner M
    Pharmacol Ther; 1998 Jun; 78(3):129-39. PubMed ID: 9690814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kip1 degradation via the ubiquitin-proteasome pathway.
    Tam SW; Theodoras AM; Pagano M
    Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation.
    An WG; Chuman Y; Fojo T; Blagosklonny MV
    Exp Cell Res; 1998 Oct; 244(1):54-60. PubMed ID: 9770348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p53 and protein kinase C independent induction of growth arrest and apoptosis by bryostatin 1 in a highly metastatic mammary epithelial cell line: In vitro versus in vivo activity.
    Wang H; Mohammad RM; Werdell J; Shekhar PV
    Int J Mol Med; 1998 Jun; 1(6):915-23. PubMed ID: 9852625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
    Diehl JA; Zindy F; Sherr CJ
    Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ubiquitin-proteasome pathway plays essential roles in ATRA-induced leukemia cells G0/G1 phase arrest and transition into granulocytic differentiation.
    Fang Y; Zhou X; Lin M; Jing H; Zhong L; Ying M; Luo P; Yang B; He Q
    Cancer Biol Ther; 2010 Dec; 10(11):1157-67. PubMed ID: 20935519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
    Wang S; Wang Z; Grant S
    Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism.
    Nguyen VA; Chen J; Hong F; Ishac EJ; Gao B
    Biochem J; 2000 Jul; 349(Pt 2):427-34. PubMed ID: 10880341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Degradation of Id proteins by the ubiquitin-proteasome pathway.
    Bounpheng MA; Dimas JJ; Dodds SG; Christy BA
    FASEB J; 1999 Dec; 13(15):2257-64. PubMed ID: 10593873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Fifty-Hertz Electromagnetic Fields on Granulocytic Differentiation of ATRA-Treated Acute Promyelocytic Leukemia NB4 Cells.
    Errico Provenzano A; Amatori S; Nasoni MG; Persico G; Russo S; Mastrogiacomo AR; Gambarara A; Fanelli M
    Cell Physiol Biochem; 2018; 46(1):389-400. PubMed ID: 29590658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1.
    Battle TE; Frank DA
    Blood; 2003 Oct; 102(8):3016-24. PubMed ID: 12855573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.